Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05974488

The Efficacy of Distal Pharyngeal Airway for Oxygenation During TEE

The Efficacy of Distal Pharyngeal Airway in Enhancing Oxygenation During Transesophageal Echocardiography (TEE) in Patients Sedated With Propofol

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
50 (estimated)
Sponsor
University of Miami · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to investigate the effect of using the McMurray Enhanced Airway (MEA) which is a flexible extended-length distal pharyngeal airway on improving oxygen delivery compared to standard nasal cannula.

Conditions

Interventions

TypeNameDescription
DEVICEMcMurray Enhanced AirwayThe MEA is non-sterile. It can be used in inpatient or outpatient surgery, in hospital or clinic settings, or in an emergency setting. The MEA has five parts: an optional 15 mm connector, flange (color-coded for size), elongated cushioned bite block, flexible cannula, and distal tip, and a channel to allow for passage of air and a suction catheter. The MEA is designed to open and maintain a patient's upper airway. Oxygen will be delivered through the breathing circuit with the following parameters: 40% oxygen at 6 liters/min flow throughout the procedure time. The MEA will be placed in the participant's oropharyngeal airway one time during an in-person visit.
DEVICENasal CannulaParticipants in this group will use the nasal cannula to deliver oxygen as per standard of care one time during the in-person visit.

Timeline

Start date
2023-11-30
Primary completion
2026-10-01
Completion
2026-10-01
First posted
2023-08-03
Last updated
2025-10-06

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT05974488. Inclusion in this directory is not an endorsement.